EXHIBIT 32.A3
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of GenOn Mid-Atlantic, LLC on Form 10-Q for the quarter ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer's knowledge:
| (1) | The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Form 10-Q. |
Date: May 2, 2017
| /s/ MARK ALLEN MCFARLAND | ||
| Mark Allen McFarland | ||
| Chief Executive Officer | ||
(Principal Executive Officer) | ||
| /s/ KIRKLAND B. ANDREWS | ||
| Kirkland B. Andrews | ||
| Chief Financial Officer | ||
(Principal Financial Officer) | ||
| /s/ DAVID CALLEN | ||
| David Callen | ||
| Chief Accounting Officer | ||
(Principal Accounting Officer) | ||
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of this Form 10-Q or as a separate disclosure document.
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to GenOn Mid-Atlantic, LLC and will be retained by GenOn Mid-Atlantic, LLC and furnished to the Securities and Exchange Commission or its staff upon request.